One injection vs. two: a new approach to shoulder surgery pain?

NCT ID NCT07762417

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a single nerve block (SPENG) can match the pain relief of a combined two-nerve block approach after shoulder arthroscopy. Adults aged 18-70 undergoing elective shoulder surgery will be randomly assigned to receive either the SPENG block or the combined suprascapular and axillary nerve blocks. The main goal is to compare the highest pain scores in the first 24 hours after surgery, while also looking at factors like how long the block takes, opioid use, and recovery quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Shoulder Posterior Pericapsular Nerve Group (SPENG) block, a single-injection ultrasound-guided nerve block procedure
What this could lead to
If the SPENG block works as well as the combined nerve blocks, it could offer a simpler, faster, and potentially safer way to manage pain after shoulder surgery.
What could go wrong
This is a small, single-center trial, and the SPENG block may not provide adequate pain relief compared to the established technique. There are also risks of nerve block complications, though rare.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.